Residency · Residency · Ophthalmology
Femtosecond Laser-Assisted Cataract Surgery
Overview
Femtosecond laser-assisted cataract surgery (FLACS) uses an infrared laser operating at 1030-1050 nm to automate several key steps of cataract surgery. The femtosecond laser delivers ultra-short pulses (on the order of 10^-15 seconds) that create photodisruption through plasma-mediated cavitation bubbles, mechanically disrupting tissue with minimal collateral thermal damage. The surgical steps amenable to laser treatment include capsulotomy, lens fragmentation, and corneal incisions (both primary wounds and arcuate keratotomies for astigmatism correction). Commercially available platforms include the LenSx (Alcon), Catalys (Johnson & Johnson), LensAR, Victus (Bausch + Lomb), and FEMTO LDV Z8 (Ziemer).
Femtosecond Laser Physics
The femtosecond laser operates in the near-infrared wavelength range (~1030-1050 nm) with pulse durations of 200-800 femtoseconds. At the focal point, the laser creates a plasma that expands as a cavitation bubble, mechanically disrupting the target tissue. Because the pulse durations are extraordinarily short, thermal damage to surrounding structures is minimal. The laser requires transparent media for delivery and cannot be used through dense corneal opacities. All current platforms incorporate integrated OCT imaging for real-time visualization of anterior segment anatomy during treatment planning.
FLACS Procedure
Patient Interface (Docking)
The first step is applying a suction ring or liquid-optic interface to stabilize the eye and create a coupling for the laser. Contact (applanation) interfaces flatten the cornea against a glass lens and may raise IOP significantly to 60-80 mmHg transiently, while non-contact (liquid-optic) interfaces use fluid-filled coupling that minimally applanates the cornea with a lower IOP rise. Docking is a critical step, with common issues including subconjunctival hemorrhage, incomplete suction, and patient anxiety. The transient IOP elevation may be concerning in patients with advanced glaucoma, and iris sphincter compression can cause transient miosis.
Capsulotomy
The laser creates a precise, circular, and highly reproducible capsulotomy with several theoretical advantages over manual capsulorrhexis: it is more circular and better centered, produces a reproducible diameter (programmable to an exact size such as 5.0 mm), and may offer more consistent edge tensile strength -- though this last point remains debated. The more precise geometry may improve IOL centration and effective lens position predictability. Disadvantages include anterior capsule tags (incomplete cuts requiring manual completion), capsule bridges (residual connections needing forceps separation), and the additional cost and time. The free-floating capsule disk must be identified and removed to prevent visual axis obstruction.
Lens Fragmentation
The laser fragments the nucleus into segments using cross, grid, or cylindrical patterns, softening dense nuclei before phacoemulsification. This consistently reduces the phacoemulsification energy required (lower CDE/EPT), which theoretically decreases endothelial cell loss from reduced ultrasound exposure. In very soft cataracts, lens fragmentation provides little additional advantage, while in very dense cataracts the laser may struggle to penetrate effectively, and the posterior capsule distance must be carefully respected.
Corneal Incisions
The laser can create the primary clear corneal incision with precise, programmable geometry and can perform arcuate keratotomies -- intrastromal arcs that correct low-to-moderate corneal astigmatism. Depth, arc length, and optical zone are fully programmable, guided by nomograms such as Donnenfeld and Holland. However, arcuate keratotomy results are more variable and less predictable than toric IOLs, particularly for higher degrees of astigmatism.
FLACS vs. Conventional Phacoemulsification Summary
| Parameter | FLACS | Conventional Phaco |
|---|---|---|
| Capsulotomy precision | Superior (programmable, more circular) | Surgeon-dependent |
| Phaco energy (CDE) | Reduced | Standard |
| Visual acuity outcomes | Equivalent (no significant difference in RCTs) | Equivalent |
| Complication rate | Similar (possibly higher anterior capsule tears) | Similar |
| Endothelial cell loss | Possibly reduced (inconsistent data) | Standard |
| Time per case | +10-15 min (docking + laser) | Standard |
| Cost per eye (consumables) | +$300-500 | None |
| Equipment cost | $400,000-500,000 | Included in phaco machine |
| Pupil issues | Miosis from prostaglandins | Rare |
| Limitations | Dense opacity, small pupils, deep orbits | Very dense nuclei need more energy |
Evidence: FLACS vs. Conventional Phacoemulsification
Potential Advantages
FLACS consistently produces a more precise capsulotomy geometry and reduces phacoemulsification energy. There is a theoretical reduction in endothelial cell loss, though this finding has been inconsistent across studies. The ability to perform arcuate keratotomies without additional instruments is an added convenience.
Lack of Demonstrated Superiority
Despite the technical precision of FLACS, multiple randomized controlled trials and meta-analyses have failed to demonstrate a significant difference in best-corrected visual acuity between FLACS and conventional phacoemulsification. Complication rates are not significantly lower, and some studies have shown higher rates of anterior capsule tears with FLACS. Evidence for reduced endothelial cell loss remains mixed, and improvements in refractive predictability are modest at best. The FEMCAT trial (2020) and European Multicenter Study both found no significant differences in visual outcomes, complications, or patient satisfaction.
Disadvantages / Limitations
The financial burden is substantial: laser systems cost approximately $400,000-$500,000, per-procedure consumables run $300-$500 per eye, and ongoing maintenance adds further expense. The procedure adds 10-15 minutes per case for docking, laser treatment, and transfer to the microscope. Prostaglandin release from laser energy can cause pupil constriction, often requiring preoperative NSAIDs or intraoperative pupil expansion. Suction-related complications include subconjunctival hemorrhage, docking failure, and transient IOP spikes. The technology is unsuitable for patients with dense corneal opacities, very small pupils, deep-set orbits, or poor cooperation.
Cost-Effectiveness Analysis
Multiple health economic analyses have concluded that FLACS is not cost-effective compared with conventional phacoemulsification for routine cataracts. The incremental cost per case is substantial while the clinical benefit is minimal or absent. Premium pricing marketed to patients as an "upgrade" is common in private practice but ethically debated. FLACS may have a niche role in specific situations: premium IOL cases where precise capsulotomy optimizes IOL centration, very dense cataracts, or teaching environments.
Current Role and Future Directions
FLACS currently accounts for approximately 5-10% of cataract surgeries in the United States and less globally. Adoption has slowed as the evidence base matured without demonstrating clear superiority. As costs decrease and platforms improve, the technology may gain wider acceptance. Integration with intraoperative aberrometry and AI-guided planning could enhance its utility. For surgical education, FLACS may provide a structured approach by handling capsulotomy and fragmentation while trainees focus on the remaining steps.
<image>Schematic diagram comparing FLACS versus conventional phacoemulsification. Two parallel flowcharts side by side. Left (FLACS): Step 1 — patient docking with suction interface and integrated OCT imaging of the anterior segment; Step 2 — laser capsulotomy (precise circular cut shown); Step 3 — laser nucleus fragmentation (grid or cross pattern shown within the lens); Step 4 — laser corneal incisions; Step 5 — surgeon moves patient to the microscope and completes phacoemulsification (with reduced energy), I/A, and IOL implantation. Right (Conventional): Step 1 — manual clear corneal incision; Step 2 — manual capsulorrhexis with cystotome or forceps; Step 3 — phacoemulsification of nucleus (full energy); Step 4 — I/A and IOL implantation. Timeline comparison showing additional time required for FLACS.</image>
<image>Intraoperative OCT images from a FLACS platform during treatment planning. Three panels: (1) Cross-sectional OCT image showing the cornea, anterior chamber, iris, anterior lens capsule, and posterior lens capsule with the laser treatment zones overlaid — capsulotomy plane marked on the anterior capsule, lens fragmentation pattern within the lens substance, and safety zones delineated from the posterior capsule and endothelium; (2) En-face view showing the planned circular capsulotomy (5.0 mm diameter) centered on the pupil; (3) En-face view showing the nuclear fragmentation pattern (cross-hatch grid). Label the safety margins and treatment parameters.</image>
<image>Comparison photographs of manual capsulorrhexis versus femtosecond laser capsulotomy. Panel A: Surgical microscope view of a manual CCC — slightly irregular edge, variable diameter. Panel B: Laser capsulotomy — perfectly circular, precise diameter (5.0 mm), centered on visual axis. Panel C: Superimposed measurement overlay showing circularity index and diameter for each. Panel D: Anterior capsule edge under electron microscopy — manual CCC showing smooth torn edge versus laser capsulotomy showing serrated, stepped edge from photodisruption. Discuss how edge characteristics relate to tensile strength.</image>
Key Clinical Pearls
FLACS produces a more precise capsulotomy and reduces phacoemulsification energy, but these technical advantages have not translated into clinically meaningful improvements in visual outcomes or safety in randomized controlled trials. The additional cost of $300-500 per eye in consumables alone is difficult to justify for routine cataracts without demonstrated superiority. Miosis from prostaglandin release during laser treatment can complicate subsequent phacoemulsification, so patients should be pre-treated with topical NSAIDs. Suction loss during docking is the most common laser-related complication; if suction breaks during capsulotomy, the cut may be incomplete and require manual completion. For toric IOL candidates, laser capsulotomy may provide marginal benefit through more precise centration. FLACS is not a replacement for surgical skill -- the surgeon must still complete phacoemulsification, cortical removal, and IOL implantation. Arcuate keratotomies with femtosecond laser are less predictable than toric IOLs for astigmatism correction, especially for cylinder greater than 1.5 D. Residents should master conventional phacoemulsification first; FLACS is an adjunct, not a substitute for fundamental surgical competence.
References
- Day AC, et al. Laser-assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery. Cochrane Database Syst Rev. 2016.
- Manning S, et al. Femtosecond laser-assisted cataract surgery versus standard phacoemulsification cataract surgery: systematic review. Ophthalmology. 2020;127(4):442-451.
- Ewe SYP, et al. A randomized controlled trial evaluating femtosecond laser-assisted cataract surgery vs. conventional phacoemulsification (FEMCAT). Am J Ophthalmol. 2020;213:1-10.
- Abell RG, et al. Femtosecond laser-assisted cataract surgery compared with conventional cataract surgery. Clin Exp Ophthalmol. 2015;43(1):32-38.
- AAO BCSC Section 11: Lens and Cataract. 2023-2024.
